Patent US2623020A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4010272A Expired / Lapsed US ⏱️ 0.0 years remaining

Anthelmintically active basically substituted 2-carbalkoxy-amino-benzimidazolyl-5(6)-phenyl ethers and -ketones

Assignee: Hoechst AG
•
Filing: 1975-09-08
•
Granted: 1977-03-01
•
Expires: 1995-09-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Anthelmintically active basically substituted 2-carbalkoxy-amino-benzimidazolyl-5(6)-phenyl ethers and -ketones are disclosed as well as a process for preparing them. The compounds are chemotherapeutics having a particular activity against ankylostomes, other helminths as well as liver fluke.

Inventors

  • 👤 Heinz Loewe
  • 👤 Josef Urbanietz
  • 👤 Dieter Duwel
  • 👤 Reinhard Kirsch

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 12:40
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/08; C07D295/084; C07D295/088; C07D235/00; C07D235/02; C07D235/04; C07D235/24; C07D235/30; C07D235/32

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 82 words
A basically substituted 2-carbalkoxyamino-benzimidazolyl5-(6)-phenyl ether or -ketone of the formula ##STR10##wherein R 3 is alkyl having 1 to 4 carbon atoms, X is oxygen, sulfur or ##STR11##Y is a straight-chained or branched alkylene of 1 to 4 carbon atoms and R 1 and R 2 represent alkyl having 1 to 4 carbon atoms, whereby R 1 and R 2 together with the supporting nitrogen atom may also represent pyrrolidine, piperidine, morpholine or thiomorpholine, and a salt thereof with a physiologically tolerable acid.
Claim 2
Dependent Claim 82 words
A basically substituted 2-carbalkoxyamino-benzimidazolyl5-(6)-phenyl ether or -ketone of the formula ##STR10##wherein R 3 is alkyl having 1 to 4 carbon atoms, X is oxygen, sulfur or ##STR11##Y is a straight-chained or branched alkylene of 1 to 4 carbon atoms and R 1 and R 2 represent alkyl having 1 to 4 carbon atoms, whereby R 1 and R 2 together with the supporting nitrogen atom may also represent pyrrolidine, piperidine, morpholine or thiomorpholine, and a salt thereof with a physiologically tolerable acid.
Claim 3
Dependent Claim 51 words
A compound as defined in claim 1, wherein R 3 is methyl, x is oxygen, sulfur or ##STR12##, Y is-(CH 2 ) 2 -- or --(CH 2 ) 3 -- and R 1 and R 2 are methyl or ethyl or together with the nitrogen atom carrying them the piperidine ring.
Claim 4
Dependent Claim 10 words
The compound as claimed in claim 1 which is 3-(2-piperidyl-ethoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl-5(6)-ether.
Claim 5
Dependent Claim 10 words
The compound as claimed in claim 1 which is 3-(2-dimethyl-amino-ethoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl-5(6)-ether.
Claim 6
Dependent Claim 10 words
The compound as claimed in claim 1 which is 3-(dimethylamino-propoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl5(6)-ether.
Claim 7
Dependent Claim 10 words
The compound as claimed in claim 1 which is 4-(2-dimethyl-amino-ethoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl-5(6)-ether.
Claim 8
Dependent Claim 10 words
The compound as claimed in claim 1 which is 4-(2-diethylamino-ethoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl-5(6)-ether.
Claim 9
Dependent Claim 10 words
The compound as claimed in claim 1 which is 4-(2-piperidyl-ethoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl-5(6)-ether.
Claim 10
Dependent Claim 11 words
The compound as claimed in claim 1 which is 4-(2-diethylamino-ethoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl-5(6)-thio ether.
Claim 11
Dependent Claim 10 words
The compound as claimed in claim 1 which is 4-(2-diethylamino-ethoxy)-phenyl-2-carbomethoxyamino-benzimidazolyl-5(6)-ketone.
Claim 12
Dependent Claim 25 words
Anthelmintic composition containing as the active ingredient an effective amount of a compound as claimed in claim 1 in admixture with a pharmaceutically acceptable carrier.
Claim 13
Dependent Claim 22 words
Method of combatting helminths which comprises administering an effective amount of a compound as claimed in claim 1 to the infected organism.

References Cited (Backward Citations)

FR2048150A5 Cited
US3657267A Cited
FR2071334A5 Cited
US3904621A Cited
US3928375A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-02-29 1980-08-30 1981-03-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-02-29 1984-08-30 1985-03-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-02-29 1988-08-30 1989-03-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag